Symbiotic Capital

Symbiotic Capital is a private, Los Angeles-based healthcare credit firm focused on providing debt financing to established life science and healthcare companies. The firm was publicly launched in August 2024 with more than $600 million in committed capital and is affiliated with Bellco Capital. Symbiotic positions itself as a science-first lender serving biotechnology, medical devices, diagnostics, tools, synthetic biology, and other healthcare subsectors. Rather than developing therapeutic products, it structures and originates credit facilities and related financing solutions for companies across the healthcare ecosystem. Its business is best understood as specialty healthcare finance rather than a drug-development biotech company.